PRANAV BHAKTA: Open Payments
NPI 1659485092 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 30 payments from 9 companies in 2025. Trend: 2023 $757 · 2024 $603 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $369 |
| Amgen Inc. | 5 | $82 |
| Indivior Inc. | 2 | $44 |
| Lilly USA, LLC | 1 | $24 |
| Antares Pharma, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: FARXIGA, OTEZLA, SUBLOCADE, EVENITY, JARDIANCE, XYOSTED, Ozempic, BREZTRI.
Industry payments across TX — which companies pay providers there.
